These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Cholinergic manipulations in the rat basolateral amygdaloid nucleus on locomotor activity induced by amphetamine. Gómez MN; Campos HA Brain Res; 1987 Feb; 404(1-2):304-6. PubMed ID: 3567573 [TBL] [Abstract][Full Text] [Related]
23. Dopaminergic-cholinergic interactions in naloxone-induced circling in morphine-dependent rats with nigral lesions. Iwamoto ET; Loh HH; Way EL Eur J Pharmacol; 1976 Jul; 38(1):39-54. PubMed ID: 986306 [TBL] [Abstract][Full Text] [Related]
24. Altered pilocarpine- or chlorpromazine-induced catalepsy after long-term treatment with cholinergic drugs. Gianutsos G Psychopharmacology (Berl); 1979 Nov; 66(2):121-5. PubMed ID: 119254 [TBL] [Abstract][Full Text] [Related]
25. Changes in dopamine agonist and antagonist activity following temporary inactivation of the neostraitum. Costall B; Naylor RJ; Pettit JC Naunyn Schmiedebergs Arch Pharmacol; 1974; 285(2):103-26. PubMed ID: 4281065 [No Abstract] [Full Text] [Related]
26. [Farnesol and neuroleptics. I. Reinforcement by farnesol of the experimental cataleptigenic effect of neuroleptics]. Binet P; Miocque M; Roux M; Rinjard P Ann Pharm Fr; 1975 May; 33(5):229-34. PubMed ID: 1239975 [No Abstract] [Full Text] [Related]
27. Tolerance phenomena with neuroleptics catalepsy, apomorphine stereotypies and striatal dopamine metabolism in the rat after single and repeated administration of loxapine and haloperidol. Asper H; Baggiolini M; Burki HR; Lauener H; Ruch W; Stille G Eur J Pharmacol; 1973 Jun; 22(3):287-94. PubMed ID: 4738903 [No Abstract] [Full Text] [Related]
28. Evidence that a nigral gabaergic--cholinergic balance controls posture. De Montis GM; Olianas MC; Serra G; Tagliamonte A; Scheel-Krüger J Eur J Pharmacol; 1979 Jan; 53(2):181-90. PubMed ID: 569589 [TBL] [Abstract][Full Text] [Related]
30. Pharmacology of neuroleptics upon repeated administration. Moller Nielsen I; Fjalland B; Pedersen V; Nymark M Psychopharmacologia; 1974 Jan; 34(2):95-104. PubMed ID: 4856370 [No Abstract] [Full Text] [Related]
31. Dopamine antagonism and antischizophrenic potency of neuroleptic drugs. Crow TJ; Gillbe C Nat New Biol; 1973 Sep; 245(140):27-8. PubMed ID: 4516939 [No Abstract] [Full Text] [Related]
32. A comparison of narcotic analgesics with neuroleptics on behavioral measures of dopaminergic activity. Lal H; Gianutsos G; Puri SK Life Sci; 1975 Jul; 17(1):29-34. PubMed ID: 238089 [No Abstract] [Full Text] [Related]
33. The behavioral pharmacology of butaclamol hydrochloride (AY-23,028), a new potent neuroleptic drug. Voith K; Herr F Psychopharmacologia; 1975 Apr; 42(1):11-20. PubMed ID: 1171496 [TBL] [Abstract][Full Text] [Related]
34. Proceedings: Comparison of circling behaviour following unilateral inhibition of GABA-transaminase or discrete electroyltic lesioning in the rat substantia nigra. Dray A; Fowler LJ; Oakley NR; Simmonds MA; Tanner T Br J Pharmacol; 1975 Oct; 55(2):288P. PubMed ID: 1238134 [No Abstract] [Full Text] [Related]
35. On stereotypy and catalepsy: studies on the effect of amphetamines and neuroleptics in rats. Fog R Acta Neurol Scand Suppl; 1972; 50():3-66. PubMed ID: 4565013 [No Abstract] [Full Text] [Related]
36. Proceedings: Analgesics and rotational behaviour in rats with unilateral substantia nigra lesions. Effects in the presence and absence of (+)-amphetamine. Br J Pharmacol; 1975 Oct; 55(2):316P. PubMed ID: 1238136 [No Abstract] [Full Text] [Related]